tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN

Urogen Pharma (URGN) Revenue

Compare
654 Followers

Urogen Pharma Revenue

Urogen Pharma had a revenue of 37.84M in the quarter ending Dec 31, 2025, with 37.68%. This bring the company's revenue in the last twelve months to 109.79M, Decreased 13.75%. In the fiscal year ending Dec 31, 2025, Urogen Pharma had annual revenue of 109.79M with 21.45% growth.
Revenue (ttm)
109.79M
Revenue Growth
8.00%
P/S Ratio
7.81
Revenue/Employee
$469,179
Employees
234
Market Cap
$857.78M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
109.79M19.39M+21.45%
Dec 31, 2024
90.40M7.68M+9.29%
Dec 31, 2023
82.71M18.36M+28.52%
Dec 31, 2022
64.36M16.32M+33.96%
Dec 31, 2021
48.04M36.24M+307.17%
Dec 31, 2020
11.80M11.78M+65,450.00%
Dec 31, 2019
18.00K-1.11M-98.40%
Dec 31, 2018
1.13M-7.03M-86.17%
Dec 31, 2017
8.16M